PATENT CLAIM ANALYSIS

Application Number: 15746506
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["435", "006110"]

Abstract:
The present invention provides a method for the prognosis of overall survival, cancer recurrence or response to treatment for a patient suffering from cancer, the method comprising: (a) examining a sample from the patient to determine whether the patient is human epidermal growth factor receptor 2 (HER2) positive or negative; and (b) measuring WW domain-binding protein 2 (WBP2) levels in the patient's sample, wherein a result in step (a) and a result in step (b) provides a prognosis of overall survival, cancer recurrence or response to treatment for the patient. The present invention also provides a kit carrying out the method of the present invention.

Claim (Index 10):
The method of  claim 4 , wherein a sample with WBP2 expression levels above the predetermined level and a HER2 negative patient provides the prognosis that the patient has an approximate 1 to 2 times higher chance of cancer recurrence compared to the reference group.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 86.0
- Lexical Diversity: 2.13559
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13383693', '13829234', '15365296', '12806419', '14343071']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6126235766642819
- 35 USC 102 Novelty (BERT): 0.523760371560474
- Combined Prediction Score: 0.6037372561539012
- Mean Citation Score: 300.4174240000001
- Max Citation Score: 302.9276
- Similarity Product: 194.31167755038737

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test